GlycoMira receives NIH Grant Award to Develop Therapeutics for Oral Mucosits

We have received an SBIR Phase I grant award to develop therapeutics for oral mucositis. Oral mucositis is a seriously painful inflammatory disease that frequently occur during cancer therapy. Currently, the treatment options for patients are extremely limited. GlycoMira is devoted to develop therapeutics for this painful side effects of cancer therapy. Please check out our research at NIH – READ MORE